NCT00470327 A Study of the Natural Progression of Interstitial Lung Disease (ILD)
| NCT ID | NCT00470327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Interstitial Lung Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2005-09 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2005-09 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Eligibility Criteria
Inclusion Criteria: * Interstitial lung disease Exclusion Criteria: * Does not have Interstitial lung disease
Contact & Investigator
Vanita Patel, MPH
📞 773-702-1012
Mary E Strek, MD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT00470327 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Interstitial Lung Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00470327 currently recruiting?
Yes, NCT00470327 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Chicago to inquire about joining.
Where is the NCT00470327 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT00470327 clinical trial?
NCT00470327 is sponsored by University of Chicago. The principal investigator is Mary E Strek, MD at University of Chicago. The trial plans to enroll 4,000 participants.